Hypothermia and cytokines in septic shock. Norasept II Study Investigators. North American study of the safety and efficacy of murine monoclonal antibody to tumor necrosis factor for the treatment of septic shock. [electronic resource]
Producer: 20001222Description: 716-21 p. digitalISSN:- 0342-4642
- Adult
- Aged
- Aged, 80 and over
- Case-Control Studies
- Cytokines -- metabolism
- Female
- Humans
- Hypothermia -- etiology
- Interleukin-6 -- blood
- Logistic Models
- Male
- Middle Aged
- North America -- epidemiology
- Risk Factors
- Shock, Septic -- complications
- Survival Rate
- Systemic Inflammatory Response Syndrome -- immunology
- Tumor Necrosis Factor-alpha -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.